AstraZeneca wins EU backing for breast cancer drug, splitting with FDA panel 

An AstraZeneca breast cancer drug received a positive opinion from European regulators, despite an FDA advisory committee voting against the drug last month. Novo Nordisk’s Wegovy pill also got the EU go-ahead. The European Medicines ...